Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

ADC Therapeutics News

Aktie
WKN:  A2PSR8 ISIN:  CH0499880968 US-Symbol:  ADCT Branche:  Biotechnologie Land:  Schweiz
4,38 $
+0,00 $
0,00%
3,7138 € 01:00:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
295,73 Mio. €
Streubesitz
27,64%
KGV
-1,33
Index-Zuordnung
-

ADC Therapeutics News

10.11.25 - PR Newswire
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update PR Newswire
03.11.25 - PR Newswire
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025 PR Newswire
27.10.25 - PR Newswire
ADC Therapeutics to Present at November Investor Conferences
ADC Therapeutics to Present at November Investor Conferences PR Newswire
13.10.25 - PR Newswire
ADC Therapeutics Announces $60 Million Private Placement
ADC Therapeutics Announces $60 Million Private Placement PR Newswire
01.10.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
02.09.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
27.08.25 - PR Newswire
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025 PR Newswire
12.08.25 - PR Newswire
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update PR Newswire
01.08.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
01.07.25 - PR Newswire
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan PR Newswire
26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
16.06.25 - PR Newswire
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-​Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant ...
12.06.25 - PR Newswire
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028 PR Newswire
12.06.25 - PR Newswire
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress PR Newswire
02.06.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
15.05.25 - PR Newswire
ADC Therapeutics to Present at Upcoming Investor Conferences
ADC Therapeutics to Present at Upcoming Investor Conferences PR Newswire
14.05.25 - PR Newswire
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update PR Newswire
14.05.25 - PR Newswire
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International ...
08.05.25 - PR Newswire
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025 PR Newswire

Newssuche

Videos

newspaper
16.04.26 -0,42%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »